EDN1 and Schnyder corneal dystrophy: Our results show that ET-1–stimulated expression of MHC class II molecules is sensitive to blockade of ET-1 receptor B by BQ788 in vitro and that in vivo MHC class II levels in SCD mice can be reduced by treatment with ET-1 receptor A and B antagonists (ETRAs).